Cerner Capital

Carevive Systems, Inc. is a company that develops a platform designed to enhance cancer care delivery and patient engagement. The platform includes Carevive PROmpt, which serves as a cancer clinical practice and patient engagement software for treatment planning, symptom management, and survivorship care, as well as offering analytics and evidence-based care plans. It also features a Treatment Care Plans engine, which utilizes rules technology for personalized treatment strategies, and a Navigation/Care Coordination module that facilitates patient eligibility tracking and care plan adherence. Additionally, Carevive Systems provides tools for risk stratification, symptom triage, and patient symptom trending, allowing clinicians to monitor patient progress effectively. The company, based in North Miami, Florida, was incorporated in 2013 and rebranded from On Q Health, Inc. in 2015. Through its solutions, Carevive Systems aims to improve clinical outcomes and support oncology practices in adapting to value-based care models.

Xealth Inc. operates a digital health prescribing platform that allows clinicians to integrate, prescribe, and monitor digital health tools directly from electronic health record (EHR) workflows. Founded in 2016 and based in Seattle, Washington, the platform facilitates patient engagement by enabling care teams to order appropriate digital health tools and programs, which can be sent to patients via email or patient portals. In addition to managing digital health prescriptions, the platform supports patient education and offers non-clinical services such as ride shares and food delivery. This comprehensive approach allows clinicians to monitor patient activity and engagement, ultimately enhancing the overall effectiveness of digital health initiatives within healthcare systems.

Carevive Systems, Inc. is a company that develops a platform designed to enhance cancer care delivery and patient engagement. The platform includes Carevive PROmpt, which serves as a cancer clinical practice and patient engagement software for treatment planning, symptom management, and survivorship care, as well as offering analytics and evidence-based care plans. It also features a Treatment Care Plans engine, which utilizes rules technology for personalized treatment strategies, and a Navigation/Care Coordination module that facilitates patient eligibility tracking and care plan adherence. Additionally, Carevive Systems provides tools for risk stratification, symptom triage, and patient symptom trending, allowing clinicians to monitor patient progress effectively. The company, based in North Miami, Florida, was incorporated in 2013 and rebranded from On Q Health, Inc. in 2015. Through its solutions, Carevive Systems aims to improve clinical outcomes and support oncology practices in adapting to value-based care models.

Voalte, Inc. is a healthcare technology company specializing in smartphone software solutions designed to enhance communication among caregivers in hospital settings. Founded in 2008 and based in Sarasota, Florida, Voalte offers a range of products, including Voalte One, which integrates VoIP calling, alarm notifications, and text messaging. Additionally, Voalte Me facilitates communication between doctors and care team members using personal smartphones, while Voalte Story promotes enterprise-level social interaction. The company also provides Voalte Connect, a mobile device management solution, alongside clinical workflow services and support. With operations in various locations including Seattle, Uruguay, Vietnam, New York, and Spain, Voalte aims to improve care coordination by ensuring that care teams can securely access and share information, adapting to future healthcare technologies. As of 2019, Voalte operates as a subsidiary of Hill-Rom, Inc.

Cureatr Inc. is a New York-based company that specializes in mobile care coordination solutions for healthcare providers. Founded in 2011, it offers a cloud-based medication management software designed to optimize patient care, particularly focusing on post-discharge medication reconciliation. The platform combines HIPAA-secure text messaging with workflow navigation tools, facilitating communication and coordination among healthcare professionals. Cureatr's software features an inbuilt dashboard that curates and analyzes patients' medication history, enabling providers to respond to real-time events and improve their interactions with patients. By streamlining these processes, Cureatr enhances the overall quality of patient care.

Sotera Wireless, Inc. is a medical device company dedicated to the development, marketing and sale of a new generation of comprehensive vital signs monitoring. Sotera’s mission is to improve patient safety by empowering clinicians to detect early signs of deterioration in virtually any care setting and enable early intervention and rapid response, all without limiting the patient’s freedom of movement.

Claritas Genomics, Inc. is a genetic diagnostic testing laboratory based in Cambridge, Massachusetts, specializing in services for pediatric disorders. Established in 2012 as a subsidiary of The Children's Hospital Corporation, the company focuses on providing a comprehensive range of genetic testing, including clinical exome analysis, single gene sequencing, and assay analysis for gene deletions and duplications. It utilizes advanced instrumentation and bioinformatics, combining these with clinical expertise from specialists at Boston Children's Hospital, a leading pediatric institution. The laboratory aims to simplify the selection of molecular tests and supports clinicians in navigating the complexities of genetic diagnostics. Its interpretive services ensure that reports convey intricate genetic information clearly, aiding in informed medical decision-making.

Sotera Wireless, Inc. is a medical device company dedicated to the development, marketing and sale of a new generation of comprehensive vital signs monitoring. Sotera’s mission is to improve patient safety by empowering clinicians to detect early signs of deterioration in virtually any care setting and enable early intervention and rapid response, all without limiting the patient’s freedom of movement.